URL copied
Vaccine shortage globally in first six months of 2021, Adar Poonawalla says
Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla on Monday said that the world will see a shortage of the coronavirus vaccine in the first six months of 2021. India is a part of COVAX. We will keep giving 50% of everything we make to India and to COVAX at the same time. India has such a large population that we will probably end up giving the majority of those 50 million doses to India first. The first six months of 2021 will see a shortage globally. Nobody can help that. But we will see easing off by August-September 2021 as other vaccine manufacturers also being able to supply, Poonawalla said.Â
Govt Must Protect Vaccine Makers From Lawsuits: Adar Poonawalla
SII CEO Adar Poonawalla s comments came a month after a 40-year old man alleged serious side effects of Covishield vaccine and asked to halt trials
PTI 20 December 2020 PTI 2020-12-20T09:38:22+05:30 Govt Must Protect Vaccine Makers From Lawsuits: Adar Poonawalla outlookindia.com 2020-12-20T09:47:24+05:30
Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla has said.
He also said that the vaccine makers are going to propose this to the government, while speaking at a virtual panel on the challenges of developing a Covid-19 vaccine at the Carnegie India s Global Technology Summit on Friday.
Coronavirus: India records 26,624 new cases, 341 deaths in 24 hours jagonews24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jagonews24.com Daily Mail and Mail on Sunday newspapers.
URL copied
Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla
Vaccine manufacturers need to have protection against all lawsuits for their vaccines especially during a pandemic, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla has said. He also said that the vaccine makers are going to propose this to the government while speaking at a virtual panel on the challenges of developing a COVID-19 vaccine at the Carnegie India s Global Technology Summit on Friday. We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that, Poonawalla said.